Hypera SA
Change company Symbol lookup
Select an option...
WILC G Willi-Food International Ltd
WTBA West Bancorporation Inc
RGSEQ Real Goods Solar Inc
CVI CVR Energy Inc
OSTK Overstock.com Inc
EGIL Edgetech International Inc
XOM Exxon Mobil Corp
AIV Apartment Investment and Management Co
VTI Vanguard Total Stock Market Index Fund ETF Shares

Health Care : Pharmaceuticals | Mid Cap Blend
Based in Brazil
Company profile

Hypera SA, formerly Hypermarcas SA, is a Brazil-based company engaged in the pharmaceuticals sector. The Company’s major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa. The Branded Prescription unit also acts as Mantecorp Skincare in dermocosmetics, with products recommended by dermatologists. Consumer Health offers non-prescription drugs, with brands such as Apracur, Benegrip, Coristina d, Engov, Epocler and Estomazil, among others. The Consumer Health unit also operates in nutritionals and vitamin supplements, with brands such as Tamarine, Vitasay, Biotonico Fontoura and Zero-Cal. Branded Generics operates under the Neo Quimica brand.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
-0.31 (-4.40%)
B/A Size
Day's High
Day's Low

10-day average volume:

Wish stock was already half off the IPO price, and earnings are pushing the price lower

7:18 pm ET May 12, 2021 (MarketWatch)

By Jeremy C. Owens

Online retailer's shares drop more than 12% in after-hours trading following quarterly report that shows double the losses analysts expected

The parent company of Wish has seen its stock deeply discounted since its initial public offering, and the price was slashed yet again in after-hours trading Wednesday.

ContextLogic Inc. (WISH), which offers the discount online-purchasing platform, reported a first-quarter loss of $128 million, or 21 cents a share, on sales of $772 million Wednesday, after reporting a loss of $66 million on sales of $440 million in the year-ago quarter. Analysts on average expected a loss of 17 cents a share on sales of $743.1 million, according to FactSet.

Wish went public at the end of last year at a price of $24 a share (https://www.marketwatch.com/story/wish-ipo-5-things-to-know-about-the-mobile-e-commerce-company-11606769658), but fell lower than that price on its first day of trading and has traded steadily lower than the IPO price since mid-February. Shares closed Wednesday with a 2.6% decline at $11.47, and dropped more than 12% in after-hours trading following the release of the results.

In a letter to shareholders, Wish -- which has advertised heavily in the past on platforms such as Facebook Inc. (FB) -- noted "increased sales and marketing costs driven by higher digital advertising costs." Executives also noted that Wish has moved into advertising on television and streaming platforms, as well as "experimenting with influencer marketing."

Executives also pointed to effects of the COVID-19 pandemic on its top customer targets, budget-minded consumers.

"We are confident we are making the right strategic decisions to grow our business for the long term," Chief Executive Piotr Szulczewski and Chief Financial Officer Rajat Bahri wrote in the letter to investors. "Last year, the value-conscious consumer demographic was disproportionately affected by the pandemic. As the economy starts to recover, we believe macro trends will have a positive impact on our business."

Wish's forecast failed to live up to analysts' expectations as well, however. Executives guided for second-quarter sales of $715 million to $730 million, while analysts on average were projecting $759 million, according to FactSet. The company also announced that former Square Inc. (SQ) executive Jackie Reses will take over as executive chair, splitting the roles of CEO and chair that were previously both held by Szulczewski.

-Jeremy C. Owens; 415-439-6400; AskNewswires@dowjones.com


(END) Dow Jones Newswires

May 12, 2021 19:18 ET (23:18 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.